The NOAEL equivalent for the cumulative body burden of cadmium: focus on proteinuria as an endpoint
Soisungwan Satarug , David A. Vesey , Aleksandra Buha Đorđević
Journal of Environmental Exposure Assessment ›› 2024, Vol. 3 ›› Issue (4) : 26
The NOAEL equivalent for the cumulative body burden of cadmium: focus on proteinuria as an endpoint
The risk of developing chronic kidney disease (CKD), signified by a decrease in the estimated glomerular filtration rate (eGFR), has been linked to long-term exposure to low levels of the metal pollutant cadmium (Cd). Proteinuria is a hallmark of CKD and predicts continued progressive functional decline of the kidney. The aim of this study was to use the extent of proteinuria for Cd health risk assessment. Data were from 405 apparently healthy Thai nationals, of whom 12.6% had an eGFR below 60 mL/min/1.73 m2 (low eGFR), and 16.3% and 13.5% had moderate and severe proteinuria. Urinary excretion of Cd (ECd) and urinary total protein (Epro) were measured and normalized to both creatinine clearance (Ccr) and creatinine excretion (Ecr). We found that the risk of having a low eGFR [prevalence odds ratio (POR) = 12.2, P < 0.001] and severe proteinuria [POR = 10.4, P = 0.001) were increased markedly for every ten-fold increase in ECd/Ccr. However, when ECd was normalized to Ecr, the association between eGFR and ECd was found to be insignificant due to non-differential errors introduced by the Ecr-normalization. Respective benchmark dose limit (BMDL) values of ECd/Ecr that increased protein excretion by 5% and 10% were 0.0536 and 0.1140 µg/g creatinine. The ECd/Ecr at which 5% of the population had Cd-related proteinuria was
Assessment imprecision / benchmark dose limit / cadmium / GFR / NOAEL equivalent / proteinuria
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
Food and Agriculture Organization of the United Nations/World Health Organization. Summary and Conclusions. In: Proceedings of the Joint FAO/WHO Expert Committee on Food Additives and Contaminants, Seventy-Third Meeting; Geneva, Switzerland; 2011. Available from: https://apps.who.int/iris/handle/10665/44521. [Last accessed on 17 Dec 2024] |
| [5] |
European Food Safety Authority (EFSA). Scientific opinion: Cadmium in food. 2009. Available from: https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2009.980. [Last accessed on 17 Dec 2024] |
| [6] |
European Food Safety Authority (EFSA). Scientific opinion: Statement on tolerable weekly intake for cadmium. 2011. Available from: https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2011.1975. [Last accessed on 17 Dec 2024] |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
Levey AS, Stevens LA, Schmid CH, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12. PMCID:PMC2763564 |
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
EFSA Scientific Committee; Hardy A, Benford D, Halldorsson T, et al. Update: use of the benchmark dose approach in risk assessment. EFSA J 2017;15:e04658. PMCID:PMC7009819 |
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
/
| 〈 |
|
〉 |